Sign inJoin free

Watch / Tech startups

Frazis on AI and Aussie biotech

28 Jan 202510:15

Frazis on AI and Aussie biotech

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Michael Frazis from Frazis Capital Partners highlights the impact of Chinese startup, DeepSeek, which has launched a cost-efficient AI model. This move sparks debate about the sustainability of business models like OpenAI's, especially as DeepSeek's AI overtakes US rival ChatGPT in downloads.

He observes how foundational models are evolving, with questions on capital expenditures affecting valuations. Michael notes companies like Apple and AWS may benefit, while OpenAI faces challenges. He examines market responses, where semiconductors highlight cyclical risks in tech investments.

In Australian biotech, Michael sees potential in companies like Clarity Pharmaceuticals (ASX:CU6) and the promising landscape despite recent sell-offs. He maintains a strong focus on Australian healthcare, remaining optimistic about companies awaiting US approvals and further growth.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy